Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

Last updated: June 23, 2022
Sponsor: Kasr El Aini Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Alopecia

Male Pattern Baldness

Hair Loss

Treatment

N/A

Clinical Study ID

NCT05435625
Laser-RF:AGA
  • Ages 18-60
  • All Genders

Study Summary

Patients with Androgenetic alopecia will be randomized into 2 groups; Group FCO2 receiving Fractional CO2 or Group FRF receiving Fractional Microneedling Radiofrequency.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • • both genders are included.
  • Patients above 18 years old.

Exclusion

Exclusion Criteria:

  • • Patients with patchy hair loss.
  • Patients with Telogen Effluvium or diffuse alopecia areata.
  • Patients with cicatricial alopecias.
  • Patients with associated inflammatory scalp disorders such as psoriasis orseborrheic dermatitis.
  • Patients with collagen vascular disorders.
  • Prior use of topical steroids on scalp in the previous 2 weeks.
  • Prior use of systemic steroids in the previous 1 month.

Study Design

Total Participants: 30
Study Start date:
January 01, 2022
Estimated Completion Date:
December 01, 2022

Study Description

Group FCO2 will be to receiving fractional CO2 to one randomized side of the scalp, and Group FRF will be receiving Fractional Microneedling radiofrequency to one randomized side of the scalp.

All patients will receive 4 sessions with 4-week intervals.each session will be followed by immediate topical application of 6 puffs (=1 mL) of minoxidil 5% solution twice daily and also in between the sessions and during follow up period

Connect with a study center

  • Kasr Al Ainy Hospital

    Cairo, El Manial 11956
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.